Non-interventional Study of Avelumab in the Treatment of Urothelial Cancer - The AVENUE NIS - AB 82/21 of AUO First-line Maintenance Therapy in Adult Patients with locally advanced or metastatic Urothelial Cancer who are progression-free after platinum-based Chemotherapy

被引：0
|
作者：
不详
机构：
来源：
UROLOGIE | 2023年 / 62卷 / 06期
关键词：
D O I：
10.1007/s00120-023-02120-6
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：672 / 673
页数：2
相关论文
共 50 条
  • [31] A phase 3, double-blind, randomized study of pamiparib versus placebo as maintenance therapy in patients with inoperable, locally advanced, or metastatic gastric cancer that responded to platinum-based first-line chemotherapy - Trial in progress
    Ciardiello, F.
    Bang, Y.
    Bendell, J.
    Cervantes, A.
    Brachmann, R.
    Zhang, Y.
    Raponi, M.
    Farin, H.
    Shen, L.
    ANNALS OF ONCOLOGY, 2018, 29
  • [32] Nomogram-based prediction of overall survival (OS) of patients (pts) with metastatic urothelial carcinoma (UC) receiving first-line platinum-based chemotherapy: retrospective international study of invasive/advanced cancer of the urothelium (RISC)
    Necchi, A.
    Sonpavde, G.
    Lo Vullo, S.
    Bamias, A.
    Crabb, S. J.
    Harshman, L.
    Bellmunt, J.
    De Giorgi, U.
    Sternberg, C.
    Ladoire, S.
    Wong, Y-N.
    Yu, E. Y.
    Chowdhury, S.
    Niegisch, G.
    Srinivas, S.
    Vaishampayan, U.
    Pal, S. K.
    Rosenberg, J.
    Mariani, L.
    Galsky, M. D.
    ANNALS OF ONCOLOGY, 2016, 27
  • [33] Real-world (rw) treatment (tx) patterns, sequencing, and outcomes in US patients (pts) with locally advanced or metastatic urothelial cancer (la/mUC) treated with avelumab first-line maintenance (1LM)
    Carson, Kenneth Robert
    Ike, Chiemeka
    Mahmoudpour, Seyed Hamidreza
    Monzon, Sebastian
    Fragkogianni, Stamatina
    Kearney, Mairead
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [34] Activity and tolerability of maintenance avelumab (AVE) immunotherapy after first-line platinum-based polychemotherapy in patients (pts) with locally advanced or metastatic squamous cell penile carcinoma: Initial results of PULSE study.
    Thiery-Vuillemin, Antoine
    Tartas, Sophie
    Mourey, Loic
    Colomba, Emeline
    Borchiellini, Delphine
    Goujon, Morgan
    Lefort, Felix
    Topart, Delphine
    Barthelemy, Philippe
    Lauridant, Geraldine
    Meurisse, Aurelia
    Vernerey, Dewi
    Massard, Vincent
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [35] A Mixed Treatment Comparison of Bevacizumab-based Therapies Relative to Doublet Platinum-based and Non-platinum-based Chemotherapy Combinations in Progression Free Survival for the Treatment of First-line Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)
    Yi, Y.
    Cope, S.
    Chouaid, C. C.
    Vergnenegre, A.
    Bischoff, H.
    Bergman, G.
    Walzer, S.
    Philips, Z.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S535 - S535
  • [36] SAFETY OUTCOMES OF OLAPARIB AS MAINTENANCE THERAPY FOLLOWING FIRST-LINE PLATINUM-BASED CHEMOTHERAPY FOR PATIENTS WITH BRCA-MUTATED METASTATIC PANCREATIC CANCER: RESULTS FROM THE POLO STUDY
    Van Kuiken, Katelyn
    Golan, Talia
    Cui, Karen
    Brickel, Neil
    Gupta, Charu
    Kindler, Hedy
    ONCOLOGY NURSING FORUM, 2022, 49 (02) : E61 - E62
  • [37] SPEAR-BLADDER (STUDY INFORMING TREATMENT PATHWAY DECISION IN BLADDER CANCER): TIMING OF TREATMENT FOLLOWING FIRST-LINE THERAPY IN PATIENTS WITH LOCALLY ADVANCED AND METASTATIC UROTHELIAL CANCER IN THE COMMUNITY ONCOLOGY SETTING IN THE UNITED STATES
    Doshi, G.
    Bhanegaonkar, A.
    Bharmal, M.
    Phatak, H.
    Boyd, M.
    Aguilar, K. M.
    Kearney, M.
    VALUE IN HEALTH, 2018, 21 : S72 - S72
  • [38] PARALLEL 303: Phase 2 randomized study of pamiparib vs placebo as maintenance therapy in patients (pts) with inoperable locally advanced or metastatic gastric cancer that responded to platinum-based first-line (1L) chemotherapy.
    Ciardiello, Fortunato
    Bang, Yung-Jue
    Bendell, Johanna C.
    Cervantes, Andres
    Dvorkin, Mikhail
    Lopez, Charles D.
    Metges, Jean-Philippe
    Sanchez, Antonio
    Calvo, Mariona
    Strickland, Andrew
    Kannourakis, George
    Muro, Kei
    Kawakami, Hisato
    Wei, Jia
    Borg, Christophe
    Mu, Song
    Zhang, Kathy
    Zhang, Maggie
    Shen, Lin
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [39] Bevacizumab (bev) combined with chemotherapy as first-line treatment in patients (pts) with metastatic colorectal cancer: Final results from a large non-interventional, community-based study
    Hildebrandt, B.
    Bruch, H. -R
    Zimber, J.
    Hahn, L.
    Lueck, A.
    Timmer, H.
    Kroening, H.
    Tondar, S.
    Kutscheidt, A.
    Broszeit-Luft, S.
    Oncology Research and Treatment, 2015, 38 : 205 - 206
  • [40] Bevacizumab (bev) combined with chemotherapy as first-line treatment in patients (pts) with advanced colorectal cancer: Final results from a large non-interventional community-based study
    Hildebrandt, B.
    Broszeit-Luft, S.
    Bruch, H. R.
    Zimber, J.
    Hahn, L.
    Lueck, A.
    Kroening, H.
    Tondar, S.
    Kutscheidt, A.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S377 - S377
12345